Bendavid C, Haddad B R, Griffin A, Huizing M, Dubourg C, Gicquel I, Cavalli L R, Pasquier L, Shanske A L, Long R, Ouspenskaia M, Odent S, Lacbawan F, David V, Muenke M
Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, 35 Convent Drive, MSC 3717, Building 35, Room 1B-203, Bethesda, MD 20892-3717, USA.
J Med Genet. 2006 Jun;43(6):496-500. doi: 10.1136/jmg.2005.037176. Epub 2005 Sep 30.
Holoprosencephaly (HPE) is the most common structural malformation of the developing forebrain. At birth, nearly 50% of children with HPE have cytogenetic anomalies. Approximately 20% of infants with normal chromosomes have sequence mutations in one of the four main HPE genes (SHH, ZIC2, SIX3, and TGIF). The other non-syndromic forms of HPE may be due to environmental factors or mutations in other genes, or potentially due to submicroscopic deletions of HPE genes. We used two complementary assays to test for HPE associated submicroscopic deletions. Firstly, we developed a multicolour fluorescent in situ hybridisation (FISH) assay using probes for the four major HPE genes and for two candidate genes (DISP1 and FOXA2). We analysed lymphoblastoid cell lines (LCL) from 103 patients who had CNS findings of HPE, normal karyotypes, and no point mutations, and found seven microdeletions. We subsequently applied quantitative PCR to 424 HPE DNA samples, including the 103 samples studied by FISH: 339 with CNS findings of HPE, and 85 with normal CNS and characteristic HPE facial findings. Microdeletions for either SHH, ZIC2, SIX3, or TGIF were found in 16 of the 339 severe HPE cases (that is, with CNS findings; 4.7%). In contrast, no microdeletion was found in the 85 patients at the mildest end of the HPE spectrum. Based on our data, microdeletion testing should be considered as part of an evaluation of holoprosencephaly, especially in severe HPE cases.
前脑无裂畸形(HPE)是发育中的前脑最常见的结构畸形。出生时,近50%的HPE患儿存在细胞遗传学异常。约20%染色体正常的婴儿在四个主要HPE基因(SHH、ZIC2、SIX3和TGIF)之一中存在序列突变。HPE的其他非综合征形式可能归因于环境因素或其他基因的突变,也可能是由于HPE基因的亚显微缺失。我们使用两种互补检测方法来检测与HPE相关的亚显微缺失。首先,我们开发了一种多色荧光原位杂交(FISH)检测方法,使用针对四个主要HPE基因以及两个候选基因(DISP1和FOXA2)的探针。我们分析了103例有HPE中枢神经系统表现、核型正常且无点突变的患者的淋巴母细胞系(LCL),发现了7例微缺失。随后,我们对424份HPE DNA样本应用了定量PCR,其中包括通过FISH研究的103份样本:339份有HPE中枢神经系统表现的样本,以及85份中枢神经系统正常但有典型HPE面部表现的样本。在339例严重HPE病例(即有中枢神经系统表现)中有16例(4.7%)检测到SHH、ZIC2、SIX3或TGIF的微缺失。相比之下,在HPE谱系最轻微一端的85例患者中未发现微缺失。基于我们的数据,微缺失检测应被视为前脑无裂畸形评估的一部分,尤其是在严重HPE病例中。